slides · global inventory
Show Traction
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 11,828
Current window 5,521-5,550
Pages 395
Rows per page 30
Slide function
5,521-5,550 of 11,828
49
Includes references to specific clinical studies and behavioral tasks (JORT).Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
53
Includes qualitative feedback from psychiatrists alongside key findings.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
54
Includes qualitative testimonials from psychiatrists to support the adoption thesis.Bionomics | Investor Presentation Deck | 59 slides · Bionomics
Pitch deck Investor relations 1 hit
07
The slide uses a stepped timeline visual to represent acquisitions, market expansions, and capital raises alongside a summary table of total assets.Business First Bancshares | IPO Presentation Deck | 47 slides · Business First Bancshares
Pitch deck Investment bank 1 hit
08
The slide highlights specific regional expansion efforts in Dallas-Fort Worth, New Orleans, and North Louisiana.Business First Bancshares | IPO Presentation Deck | 47 slides · Business First Bancshares
Pitch deck Investment bank Loop · Day In Life1 hit
09
The slide highlights a 51% growth in average total AUM since the closing of the acquisition.Business First Bancshares | IPO Presentation Deck | 47 slides · Business First Bancshares
Pitch deck Investment bank Loop · Day In Life1 hit
10
The slide uses a donut chart to visualize the split between sold and retained loan participations.Business First Bancshares | IPO Presentation Deck | 47 slides · Business First Bancshares
Pitch deck Investment bank Loop · Day In Life1 hit
11
The table includes a breakdown of loans and deposits by region, comparing 2021 and 2022 figures with calculated growth and L/D ratios.Business First Bancshares | IPO Presentation Deck | 47 slides · Business First Bancshares
Pitch deck Investment bank Loop · Day In Life1 hit
12
Includes detailed footnotes regarding non-GAAP financial measures.Business First Bancshares | IPO Presentation Deck | 47 slides · Business First Bancshares
Pitch deck Investment bank 1 hit
16
The slide uses a timeline-based flow to illustrate the net change in banking centers through acquisitions, de novo openings, and closures/sales.Business First Bancshares | IPO Presentation Deck | 47 slides · Business First Bancshares
Pitch deck Investment bank 1 hit
21
The slide uses a map to show physical locations and a timeline to show historical growth milestones.Business First Bancshares | IPO Presentation Deck | 47 slides · Business First Bancshares
Pitch deck Investment bank Beat · Solution1 hit
10
The slide highlights clinical efficacy and safety data from a Nature Medicine study (Mackensen et al., 2022) relevant to the company's CABA-201 construct.Cabaletta Bio | Investor Presentation Deck | 23 slides · Cabaletta Bio
Pitch deck Investor relations 1 hit
16
Includes detailed scientific citations and specific cohort dosing strategies.Cabaletta Bio | Investor Presentation Deck | 23 slides · Cabaletta Bio
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
09
Includes regulatory status and financial terms of the licensing deal.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
14
Dare Bioscience | Investor Presentation Deck | 50 slidesDare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations Beat · Financials1 hit
19
The slide highlights a key business development milestone involving a $10M upfront payment and potential $182.5M in milestones.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
27
Highlights the validation of the product by a major industry player (Bayer) and the financial terms of the deal.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
28
Includes a testimonial/quote from a partner at the bottom.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
34
The slide outlines the methodology and status of a clinical trial.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
35
The slide uses clinical trial data to justify the pivot to a topical delivery mechanism.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
36
Includes both tabular pharmacokinetic data and a line chart showing plasma concentration over time.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
42
The slide details results from two completed studies (Phase 1 and Phase 1/2) for a hormone therapy product.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
45
The slide presents clinical trial data comparing baseline to month 3 outcomes and systemic absorption levels.Dare Bioscience | Investor Presentation Deck | 50 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
17
The slide presents visual evidence (photos of tumors) alongside quantitative bar charts showing efficacy metrics.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
26
The chart shows a significant drop in viral load after day 14, maintaining a low level from day 145 onwards.Enochian Biosciences | Investor Presentation Deck | 39 slides · Enochian BioSciences
Pitch deck Investor relations 1 hit
15
Includes a competitive patent count chart and a categorical breakdown of granted patents.Faraday Future | Investor Presentation Deck | 39 slides · Faraday Future
Pitch deck Investor relations 1 hit
19
The slide uses a split layout with status bullets on the left and photographic evidence of the facility on the right.Faraday Future | Investor Presentation Deck | 39 slides · Faraday Future
Pitch deck Investor relations 1 hit
13
Includes medical imaging showing metabolic response in a patient.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
14
The table displays individual patient outcomes including tumor regression and disease stability.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit
15
The slide presents two line charts comparing tumor volume over time across different treatment groups. It includes statistical significance markers (p-values) for the combination therapies.Genprex | Investor Presentation Deck | 44 slides · Genprex
Pitch deck Investor relations Beat · Satisfaction1 hit